153 related articles for article (PubMed ID: 18509104)
1. Antibodies against GM1 in demented patients.
Hatzifilippou E; Koutsouraki E; Banaki T; Traka M; Costa VG; Baloyannis SJ
Am J Alzheimers Dis Other Demen; 2008; 23(3):274-9. PubMed ID: 18509104
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to GM1 and GQ1bα are not biological markers of Alzheimer's disease.
Miura Y; Miyaji K; Chai YL; Chen CL; Lai MK; Yuki N
J Alzheimers Dis; 2014; 42(4):1165-9. PubMed ID: 25024341
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against gangliosides in patients with dementia.
Hatzifilippou E; Koutsouraki E; Costa VG; Baloyannis SJ
Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):660-6. PubMed ID: 24838532
[TBL] [Abstract][Full Text] [Related]
4. Anti-GM1 antibodies in polyneuropathies of unknown origin.
Finsterer J; Muellbacher W; Halbmayer WM; Fischer M; Mamoli B
J Clin Pathol; 1996 May; 49(5):422-5. PubMed ID: 8707962
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to ganglioside GM1 in patients with Alzheimer's disease.
Chapman J; Sela BA; Wertman E; Michaelson DM
Neurosci Lett; 1988 Mar; 86(2):235-40. PubMed ID: 3368123
[TBL] [Abstract][Full Text] [Related]
6. Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain-Barré syndrome.
Cats EA; van der Pol WL; Tio-Gillen AP; Diekstra FP; van den Berg LH; Jacobs BC
J Neurol Neurosurg Psychiatry; 2015 May; 86(5):502-4. PubMed ID: 25157033
[TBL] [Abstract][Full Text] [Related]
7. Acute immune polyneuropathies: correlations of serum antibodies to Campylobacter jejuni and Helicobacter pylori with anti-GM1 antibodies and clinical patterns of disease.
Nevo Y; Pestronk A
J Infect Dis; 1997 Dec; 176 Suppl 2():S154-6. PubMed ID: 9396701
[TBL] [Abstract][Full Text] [Related]
8. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
[TBL] [Abstract][Full Text] [Related]
9. Anti-GM1 ganglioside antibodies in Parkinson's disease.
Zappia M; Crescibene L; Bosco D; Arabia G; Nicoletti G; Bagalà A; Bastone L; Napoli ID; Caracciolo M; Bonavita S; Di Costanzo A; Gambardella A; Quattrone A
Acta Neurol Scand; 2002 Jul; 106(1):54-7. PubMed ID: 12067330
[TBL] [Abstract][Full Text] [Related]
10. Two cases of acute anti-GM1 antibody elevations in response to exogenous GM1 without neurological symptoms.
Ala TA; Perfetti PA; Frey WH
J Neuroimmunol; 1994 Aug; 53(1):109-13. PubMed ID: 8051293
[TBL] [Abstract][Full Text] [Related]
11. Dementia and antiphospholipid antibodies.
Mosek A; Yust I; Treves TA; Vardinon N; Korczyn AD; Chapman J
Dement Geriatr Cogn Disord; 2000; 11(1):36-8. PubMed ID: 10629360
[TBL] [Abstract][Full Text] [Related]
12. [Mental competence and neuropsychologic impairments in demented patients].
Vollmann J; Kühl KP; Tilmann A; Hartung HD; Helmchen H
Nervenarzt; 2004 Jan; 75(1):29-35. PubMed ID: 14722659
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy.
Nobile-Orazio E; Giannotta C; Musset L; Messina P; Léger JM
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):754-8. PubMed ID: 23907602
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell-derived model.
Harschnitz O; van den Berg LH; Johansen LE; Jansen MD; Kling S; Vieira de Sá R; Vlam L; van Rheenen W; Karst H; Wierenga CJ; Pasterkamp RJ; van der Pol WL
Ann Neurol; 2016 Jul; 80(1):71-88. PubMed ID: 27130524
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm.
Agüero-Torres H; Fratiglioni L; Guo Z; Viitanen M; Winblad B
J Am Geriatr Soc; 1998 Apr; 46(4):444-52. PubMed ID: 9560066
[TBL] [Abstract][Full Text] [Related]
16. Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg).
van Schaik IN; Vermeulen M; van Doorn PA; Brand A
J Neuroimmunol; 1994 Oct; 54(1-2):109-15. PubMed ID: 7929799
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to GM1: galactocerebroside complexes in multifocal motor neuropathy: it takes two to tango.
Willison HJ; Galban-Horcajo F; Halstead SK
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):715. PubMed ID: 24006050
[No Abstract] [Full Text] [Related]
18. ELISA-type titertray assay of IgM anti-GM1 autoantibodies.
Bech E; Jakobsen J; Orntoft TF
Clin Chem; 1994 Jul; 40(7 Pt 1):1331-4. PubMed ID: 8013109
[TBL] [Abstract][Full Text] [Related]
19. Human IgM anti-GM1 autoantibodies modulate intracellular calcium homeostasis in neuroblastoma cells.
Quattrini A; Lorenzetti I; Sciorati C; Corbo M; Previtali SC; Feltri ML; Canal N; Wrabetz L; Nemni R; Clementi E
J Neuroimmunol; 2001 Mar; 114(1-2):213-9. PubMed ID: 11240034
[TBL] [Abstract][Full Text] [Related]
20. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls.
Uetz-von Allmen E; Sturzenegger M; Rieben R; Rihs F; Frauenfelder A; Nydegger UE
Eur Neurol; 1998; 39(2):103-10. PubMed ID: 9520071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
